La Fleur & Godfrey LLC Insulet Corp Transaction History

La Fleur & Godfrey LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 18, 2023	SELL	$154.67 - $290.89 $91,255 - $171,625	-590 Reduced 17.85%	2,716 $433,000
Q2 2023 Jul 20, 2023	BUY	$272.48 - $330.23 $306,540 - $371,508	1,125 Added 51.58%	3,306 $953,000
Q1 2023 Apr 18, 2023	BUY	$276.36 - $326.03 $16,028 - $18,909	58 Added 2.73%	2,181 $695,000
Q4 2022 Jan 12, 2023	BUY	$212.22 - $313.46 $22,283 - $32,913	105 Added 5.2%	2,123 $0
Q3 2022 Oct 17, 2022	BUY	$224.6 - $281.45 $453,242 - $567,966	2,018 New	2,018 $463,000

685

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.2B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of La Fleur & Godfrey LLC, based on Form 13F filings with the SEC.

Stay updated on La Fleur & Godfrey LLC with notifications on news.